SISRAM MED's subsidiary has reached a strategic cooperation with internationally renowned skincare expert Jamie Sherrill
SISRAM MED's wholly-owned subsidiary Alma Lasers Ltd. has reached a strategic partnership with internationally renowned skincare expert Jamie Sherrill. This collaboration aims to enhance consumer engagement and solidify Alma's leadership position in the high-end aesthetic technology sector. Jamie Sherrill will serve as the strategic promotion representative for Alma's flagship equipment platform, leading global promotional activities to increase brand awareness and accelerate the market penetration of aesthetic solutions. This partnership is expected to enhance consumer awareness of Alma's high-end solutions and create new growth opportunities for clinics worldwide
According to the Zhitong Finance APP, SISRAM MED (01696) announced that its wholly-owned subsidiary, Alma Lasers Ltd. (Alma), a provider of aesthetic solutions for energy-based medical devices, has reached a strategic partnership with internationally renowned skincare expert, entrepreneur, and widely recognized international opinion leader in the medical aesthetics field, Jamie Sherrill (Nurse Jamie). This collaboration marks an important step for Alma in enhancing consumer engagement and solidifying its leadership position in high-end aesthetic technology.
Jamie Sherrill is a registered nurse specializing in aesthetics, who has extensive influence and a well-known clientele online, thanks to her evidence-based medical philosophy and innovative treatment solutions. Through this partnership, Jamie Sherrill will serve as the strategic promotion representative for Alma's flagship equipment platforms (including the Alma Harmony and Opus series), leading global promotional activities to enhance the company's brand recognition worldwide and accelerate the penetration of the company's aesthetic solutions in the consumer market.
The company believes that the collaboration with Jamie Sherrill will further enhance consumer awareness of Alma's high-end solutions while creating stronger demand for global clinic partners and opening up new growth opportunities
